John Armitage
Egerton Capital
John Armitage Cenovus Energy Inc stake
total: 222
Egerton Capital CVE trades
- Total transactions:
- 10
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 6
- Held since:
- 2022 Q2
- Held for:
- 9 quarters
- Latest activity:
- 2024 Q3
According to 2026 Q2 report, John Armitage doesn't hold any Cenovus Energy Inc (CVE) shares. To date, the estimated cost basis is nearly $18.26 for "buy" trades and estimated average "sell" price is $18.04. Egerton Capital first purchased CVE in 2022 Q2, initially acquiring about 18.34M shares. Since the initial investment in Cenovus Energy Inc (CVE), Egerton Capital has made 9 more transactions.
When did John Armitage sell Cenovus Energy Inc (CVE)?
John Armitage sold off the entire Cenovus Energy Inc (CVE) position in 2024 Q3.
When did John Armitage buy Cenovus Energy Inc (CVE)?
John Armitage first invested in Cenovus Energy Inc (CVE) in 2022 Q2 at the reported quarter-end price of $19.01 per share.
What's the cost basis of Egerton Capital's CVE stake?
The estimated cost basis for Cenovus Energy Inc (CVE) stake is around $18.26 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $18.26
- Weighted AVG sell price:
- $18.04
John Armitage's historical trades in Cenovus Energy Inc
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q3
|
0.00%
|
0
|
$19.66
|
|
-100% (-10,322,992)
|
-2.05%
|
|
2024 Q2
|
2.05%
|
10,322,992
|
$19.66
|
$202,950,023
|
-26.10% (-3,644,951)
|
-0.69%
|
|
2024 Q1
|
2.70%
|
13,967,943
|
$19.99
|
$279,219,181
|
-1.59% (-225,108)
|
-0.05%
|
|
2023 Q4
|
2.56%
|
14,193,051
|
$16.65
|
$236,314,299
|
-36.60% (-8,194,337)
|
-1.58%
|
|
2023 Q3
|
5.41%
|
22,387,388
|
$20.82
|
$466,105,418
|
+45.32% (+6,981,420)
|
+1.69%
|
|
2023 Q2
|
2.70%
|
15,405,968
|
$16.98
|
$261,593,337
|
-38.71% (-9,728,452)
|
-1.78%
|
|
2023 Q1
|
4.74%
|
25,134,420
|
$17.46
|
$438,846,973
|
-12.51% (-3,593,767)
|
-0.54%
|
|
2022 Q4
|
4.80%
|
28,728,187
|
$19.41
|
$557,614,110
|
-1.73% (-505,443)
|
-0.08%
|
|
2022 Q3
|
3.49%
|
29,233,630
|
$15.37
|
$449,321,000
|
+59.43% (+10,897,650)
|
+1.3%
|
|
2022 Q2
|
2.35%
|
18,335,980
|
$19.01
|
$348,567,000
|
new
|
+2.35%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.